A story of a client of the General Health Insurance Company of the Czech Republic
Authors:
A. Mareček
Published in:
Listy rev. Lék., 10, 2006, č. 1, s. 13-14
Overview
Covering the treatment of a child affected by the autosomal recessive immunodeficiency of the ADA enzyme from the funds of public health insurance.
Key words:
immunodeficiency of the ADA enzyme – unique haplotype – substitution of the PEG ADA enzyme – genic therapy
Labels
Medical assessment Occupational medicineArticle was published in
Revision Medicine Journal
2006 Issue 1
Most read in this issue